Privia Health Group Inc.
PRVA | NASDAQ
$19.54
-$0.31 (-1.56%)
At close: Sep 21, 2026, 4:00 PM ET
$19.66
+$0.12 (+0.62%)
Pre-market:
Sep 22, 2026, 5:05 AM ET
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Revenue | 2.12B | 1.74B | 1.66B | 1.36B | 966.22M | 817.08M |
Cost of Revenue | 1.91B | 1.56B | 1.5B | 1.22B | 902.56M | 734.49M |
Gross Profit | 209.43M | 176.85M | 161.5M | 134.78M | 63.66M | 82.58M |
Operating Income | 34.24M | 16.98M | 20.65M | -19.12M | -217.44M | 25.38M |
Interest Income | 9.7M | 10.89M | 8.37M | 542K | n/a | n/a |
Pretax Income | 43.94M | 27.87M | 29.02M | -18.58M | -218.51M | 23.46M |
Net Income | 22.92M | 14.39M | 23.08M | -8.59M | -188.23M | 31.24M |
Selling & General & Admin | 165.29M | 152.6M | 134.32M | 149.33M | 278.63M | 55.36M |
Research & Development | n/a | n/a | n/a | n/a | n/a | n/a |
Other Expenses | 9.91M | 7.27M | 6.53M | 4.57M | 2.46M | 1.84M |
Operating Expenses | 175.2M | 159.87M | 140.85M | 153.9M | 281.1M | 57.2M |
Interest Expense | n/a | n/a | n/a | n/a | 1.07M | 1.92M |
Selling & Marketing Expenses | 27.14M | 26.45M | 24.73M | 19.74M | 22.75M | 11.34M |
Cost & Expenses | 2.09B | 1.72B | 1.64B | 1.38B | 1.18B | 791.7M |
Income Tax Expense | 14.21M | 10.83M | 7.99M | -6.52M | -27.86M | -7.44M |
Shares Outstanding (Basic) | 122.18M | 119.4M | 116.73M | 110.7M | 107.84M | 105.71M |
Shares Outstanding (Diluted) | 128.89M | 125.61M | 124.69M | 110.7M | 107.84M | 105.71M |
EPS (Basic) | 0.19 | 0.12 | 0.20 | -0.08 | -1.77 | 0.30 |
EPS (Diluted) | 0.18 | 0.11 | 0.19 | -0.08 | -1.77 | 0.30 |
EBITDA | 53.85M | 35.14M | 35.55M | -14.01M | -214.97M | 27.22M |
EBIT | 43.94M | 27.87M | 29.02M | -18.58M | -217.44M | 25.38M |
Depreciation & Amortization | 9.91M | 7.27M | 6.53M | 4.57M | 2.46M | 1.84M |
Add to Watchlist
Select watchlists to add or remove PRVA